2017-2018 Influenza Season

 

2017-2018 Influenza Vaccination Recommendations:

Visit ACOG's Influenza Season Newsletter for monthly updates on the Influenza season!

Pregnant Women:
Pregnant women are at particularly high risk of severe illness and complications from influenza disease. Learn more at the Flu & Pregnancy page.'

ACOG Flu & Pregnancy Resources

The 2017-2018 Influenza Vaccine:

On March 9, 2017, the Food and Drug Administration's Vaccines and Related Biologics Advisory Committee (VRBPAC) endorsed the WHO-recommended vaccine viruses for use in all U.S. seasonal flu vaccines for the 2017-2018 flu season. It was recommended that trivalent vaccines for use in the 2017-2018 influenza season (Northern Hemisphere winter) contain the following:

  • an A/Michigan/45/2015 (H1N1)pdm09-like virus;
  • an A/Hong Kong/4801/2014 (H3N2)-like virus;
  • a B/Brisbane/60/2008-like virus (B/Victoria lineage).

It was recommended that quadrivalent vaccines containing two influenza B viruses contain the above three viruses and a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

This represents an update in the H1N1 component of the vaccine compared to 2016-2017 Northern Hemisphere seasonal influenza vaccines.

 

Vaccination Coverage during 2016-2017 Season will be posted here once released.

 


flu shot in pregnancy

Flu vaccination: a growing trend among pregnant women

This website is supported by an independent educational grant from Merck and an educational grant from Sanofi Pasteur U.S. 
ACOG does not allow companies to influence its programs, publications, or advocacy positions.